In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Following the federal government's changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are ...

Kavita Nair, PhD, FAAN, shares how new therapies and ongoing clinical trials are reshaping the future of neurological care and offering new hope to patients.

By reducing inflammation, the researchers were able to prevent both the buildup of immune cells and the formation of these ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

More than a third of older Singaporean adults have undiagnosed age-related eye diseases, increasing visual impairment risk.

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The Indianapolis drug giant's stock (LLY) reached an intraday high of $1,061.17 in morning trading Friday, which was above the threshold of $1,057.78 needed for Lilly to become the 10th U.S. company ...